Inovio: EU Grants Orphan Drug Designation For INO-3107

WASHINGTON (dpa-AFX) - Inovio (INO) said that the European Commission granted orphan drug designation for INO-3107, the company's product candidate for the treatment of Recurrent Respiratory Papillomatosis

Related Keywords

Washington ,United States ,Gewinn Nur ,European Committee For Orphan Medicinal Products ,More Such Health News ,European Union ,European Commission ,Recurrent Respiratory Papillomatosis ,European Committee ,Orphan Medicinal Products ,Drug Administration ,Inovio ,Migrants ,Orphan ,Drug ,Resignation ,107 ,